Acne is one of the most common skin conditions seen in general practice. Acne vulgaris—the most prevalent form—affects more ...

To treat whiteheads and blackheads, try retinol or salicylic acid, but nodules and cysts are better treated with oral ...

Compared to other acne forms, cystic acne causes the largest and most painful blemishes. It is also the most difficult to ...

A sebum-selective 1726-nm laser treatment provides year-long control of moderate-to-severe acne across all skin types, with ...

Step into your local drugstore and you’ll come across countless cleansers, serums, lotions and masks all promising the same thing: fewer acne breakouts and clearer, smoother skin. Unfortunately, not ...

Oral treatment with the novel fatty acid synthase inhibitor denifanstat induced significant improvements in moderate-to-severe acne.

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.

Use of oral spironolactone in women with acne vulgaris was effective and not associated with increased adverse event risk compared with placebo.